Format

Send to

Choose Destination
Nat Rev Neurosci. 2011 May;12(5):284-96. doi: 10.1038/nrn3012. Epub 2011 Mar 30.

Linking lipids to Alzheimer's disease: cholesterol and beyond.

Author information

1
Department of Pathology and Cell Biology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, 630 West 168th Street, New York, New York 10032, USA. gil.dipaolo@columbia.edu

Erratum in

  • Nat Rev Neurosci. 2011 Aug;12(8):484.

Abstract

Lipid-mediated signalling regulates a plethora of physiological processes, including crucial aspects of brain function. In addition, dysregulation of lipid pathways has been implicated in a growing number of neurodegenerative disorders, such as Alzheimer's disease (AD). Although much attention has been given to the link between cholesterol and AD pathogenesis, growing evidence suggests that other lipids, such as phosphoinositides and phosphatidic acid, have an important role. Regulators of lipid metabolism (for example, statins) are a highly successful class of marketed drugs, and exploration of lipid dysregulation in AD and identification of novel therapeutic agents acting through relevant lipid pathways offers new and effective options for the treatment of this devastating disorder.

PMID:
21448224
PMCID:
PMC3321383
DOI:
10.1038/nrn3012
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center